ELMD Electromed Inc

  1. Stocks
  2. Healthcare
  3. NYSEAMERICAN: ELMD

Price (delayed)

$38.61

Market cap

$319.69M

P/E Ratio

31.65

Dividend/share

N/A

EPS

$1.22

Enterprise value

$302.71M

?
Relative Growth: Rel. Growth: 97
Relative Strength: Rel. Strength: 88
Relative Valuation: Rel. Valuation: 51
Relative Profitability: Rel. Profitability: 95

Electromed manufactures, markets, and sells products that provide airway clearance therapy, including the SmartVest® Airway Clearance System, to patients with compromised pulmonary function. The Company is headquartered in New Prague, ...

Highlights
Electromed's EPS has increased by 47% YoY and by 14% from the previous quarter
The net income has grown by 41% year-on-year and by 12% since the previous quarter
ELMD's P/E is 31% above its last 4 quarters average of 24.1 but 5% below its 5-year quarterly average of 33.3
The company's quick ratio rose by 3.5% QoQ but it fell by 2.6% YoY
Sector: Healthcare
Industry: Medical Devices
Website: http://www.electromed.com
Peers: RMD INGN MMSI

Key stats

What are the main financial stats of ELMD

ELMD stock price

How has the Electromed stock price performed over time
Intraday
0.55%
1 week
2.82%
1 month
1.02%
1 year
81.69%
YTD
32.59%
QTD
64.93%

Financial performance

How have Electromed's revenue and profit performed over time
Revenue
$71.75M
Gross profit
$56.28M
Operating income
$13.1M
Net income
$10.1M
Gross margin
78.4%
Net margin
14.1%
ELMD's operating income is up by 46% year-on-year and by 14% since the previous quarter
The net income has grown by 41% year-on-year and by 12% since the previous quarter
Electromed's operating margin has increased by 25% YoY and by 10% QoQ
Electromed's net margin has increased by 21% YoY and by 8% from the previous quarter

Price vs fundamentals

How does ELMD's price correlate with its fundamentals

Growth

What is Electromed's growth rate over time

Valuation

What is Electromed stock price valuation
ELMD P/E details
P/E
31.65
P/B
6.5
P/S
4.42
EV/EBIT
22.3
EV/EBITDA
20.52
EV/Sales
4.22
Electromed's EPS has increased by 47% YoY and by 14% from the previous quarter
ELMD's P/E is 31% above its last 4 quarters average of 24.1 but 5% below its 5-year quarterly average of 33.3
The price to book (P/B) is 90% higher than the 5-year quarterly average of 3.4 and 44% higher than the last 4 quarters average of 4.5
The equity rose by 12% year-on-year and by 8% since the previous quarter
The stock's price to sales (P/S) is 69% more than its 5-year quarterly average of 2.6 and 46% more than its last 4 quarters average of 3.0
ELMD's revenue is up by 17% year-on-year and by 4.2% since the previous quarter

Efficiency

How efficient is Electromed business performance
The ROE has grown by 34% YoY and by 9% from the previous quarter
The company's return on assets rose by 31% YoY and by 9% QoQ
The ROIC has grown by 28% YoY and by 10% from the previous quarter
Electromed's ROS has increased by 21% YoY and by 9% from the previous quarter

Dividends

What is ELMD's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for ELMD.

Financial health

How did Electromed financials performed over time
Electromed's total liabilities has increased by 21% YoY and by 9% QoQ
ELMD's total assets is up by 13% YoY and by 8% QoQ
Electromed's debt is 100% less than its equity
The equity rose by 12% year-on-year and by 8% since the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.